Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2023

BUY
$4.81 - $6.99 $429,407 - $624,025
89,274 New
89,274 $490,000
Q1 2022

May 09, 2022

SELL
$4.81 - $6.99 $1.56 Million - $2.27 Million
-324,973 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$5.97 - $7.93 $1.94 Million - $2.58 Million
324,973 New
324,973 $2.21 Million
Q3 2021

Nov 14, 2022

BUY
$4.79 - $6.68 $1.56 Million - $2.17 Million
324,973 New
324,973 $1.98 Million
Q3 2021

Nov 05, 2021

SELL
$4.79 - $6.68 $2.17 Million - $3.02 Million
-452,226 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$5.35 - $6.35 $2.42 Million - $2.87 Million
452,226 New
452,226 $2.67 Million
Q2 2021

Aug 10, 2021

SELL
$5.35 - $6.35 $3.34 Million - $3.96 Million
-624,027 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$5.68 - $7.87 $3.54 Million - $4.91 Million
624,027 New
624,027 $3.75 Million
Q1 2021

May 07, 2021

SELL
$5.68 - $7.87 $7.12 Million - $9.86 Million
-1,253,399 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$5.25 - $8.56 $6.58 Million - $10.7 Million
1,253,399 New
1,253,399 $8.67 Million
Q4 2020

Feb 10, 2021

SELL
$5.25 - $8.56 $6.93 Million - $11.3 Million
-1,320,649 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$5.78 - $7.47 $7.63 Million - $9.87 Million
1,320,649 New
1,320,649 $8.27 Million
Q3 2020

Nov 10, 2020

SELL
$5.78 - $7.47 $7.63 Million - $9.87 Million
-1,320,649 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$4.5 - $7.02 $5.94 Million - $9.27 Million
1,320,649 New
1,320,649 $8.72 Million
Q2 2020

Aug 07, 2020

SELL
$4.5 - $7.02 $5.6 Million - $8.73 Million
-1,243,595 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$2.87 - $5.49 $3.57 Million - $6.83 Million
1,243,595 New
1,243,595 $5.78 Million
Q1 2020

May 08, 2020

SELL
$2.87 - $5.49 $3.57 Million - $6.83 Million
-1,243,595 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$3.84 - $4.86 $4.78 Million - $6.04 Million
1,243,595 New
1,243,595 $5.25 Million
Q4 2019

Feb 12, 2020

SELL
$3.84 - $4.86 $4.78 Million - $6.04 Million
-1,243,595 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$4.86 - $6.05 $6.04 Million - $7.52 Million
1,243,595 New
1,243,595 $6.41 Million
Q3 2019

Nov 08, 2019

SELL
$4.86 - $6.05 $6.04 Million - $7.52 Million
-1,243,595 Closed
0 $0
Q2 2019

Aug 13, 2020

BUY
$4.51 - $6.6 $5.61 Million - $8.21 Million
1,243,595 New
1,243,595 $6.99 Million
Q2 2019

Aug 09, 2019

SELL
$4.51 - $6.6 $11.6 Million - $16.9 Million
-2,563,600 Closed
0 $0
Q4 2018

Mar 04, 2019

BUY
$4.89 - $7.16 $12.5 Million - $18.4 Million
2,563,600 New
2,563,600 $13 Million
Q4 2018

Feb 08, 2019

SELL
$4.89 - $7.16 $10.2 Million - $14.9 Million
-2,084,225 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$6.89 - $7.78 $14.4 Million - $16.2 Million
2,084,225 New
2,084,225 $15 Million
Q3 2018

Nov 09, 2018

SELL
$6.89 - $7.78 $11.6 Million - $13.1 Million
-1,685,405 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$5.19 - $7.25 $8.75 Million - $12.2 Million
1,685,405 New
1,685,405 $11.2 Million
Q2 2018

Jul 23, 2018

SELL
$5.19 - $7.25 $6.5 Million - $9.08 Million
-1,252,357 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$3.56 - $5.74 $4.46 Million - $7.19 Million
1,252,357 New
1,252,357 $6.86 Million
Q1 2018

May 09, 2018

SELL
$3.56 - $5.74 $3.68 Million - $5.93 Million
-1,032,357 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$2.76 - $3.95 $2.85 Million - $4.08 Million
1,032,357 New
1,032,357 $3.49 Million
Q4 2017

Feb 09, 2018

SELL
$2.76 - $3.95 $2.85 Million - $4.08 Million
-1,032,357 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$2.22 - $2.73 $2.29 Million - $2.82 Million
1,032,357 New
1,032,357 $2.82 Million
Q3 2017

Nov 07, 2017

SELL
$2.22 - $2.73 $1.74 Million - $2.14 Million
-783,135 Closed
0 $0
Q1 2017

May 11, 2018

BUY
N/A
240,000 Added 44.19%
783,135 $3.49 Million
Q3 2016

Nov 13, 2017

BUY
N/A
543,135
543,135 $0

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.